Cytokine Armored GPC3 CAR-T

· Seattle Children's Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cytokine Armored GPC3 CAR-T, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors [Phase 1]